Related Experiment Video
Updated: Apr 11, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Epigenetic Regulation of miRNAs and Breast Cancer Stem Cells
Nadire Duru1, Ramkishore Gernapudi1, Gabriel Eades1
1Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201.
Abstract:
MicroRNAs have emerged as important targets of chemopreventive strategies in breast cancer. We have found that miRNAs are dysregulated at an early stage in breast cancer, in non-malignant Ductal Carcinoma In Situ. Many dietary chemoprevention agents can act by epigenetically activating miRNA-signaling pathways involved in tumor cell proliferation and invasive progression. In addition, many miRNAs activated via chemopreventive strategies target cancer stem cell signaling and prevent tumor progression or relapse. Specifically, we have found that miRNAs regulate DCIS stem cells, which may play important roles in breast cancer progression to invasive disease. We have shown that chemopreventive agents can directly inhibit DCIS stem cells and block tumor formation in vivo, via activation of tumor suppressor miRNAs.
Insights
Chemopreventive strategies targeting microRNAs (miRNAs) show promise for breast cancer. These agents can epigenetically activate tumor-suppressing miRNAs, inhibiting ductal carcinoma in situ stem cells and preventing invasive progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial regulators in cancer development and progression.
- Dysregulation of miRNAs is observed early in breast cancer, even in non-malignant stages like Ductal Carcinoma In Situ (DCIS).
- Dietary chemopreventive agents offer potential therapeutic strategies by modulating miRNA expression.
Purpose of the Study:
- To investigate the role of miRNAs in early breast cancer, specifically DCIS.
- To explore how chemopreventive agents impact miRNA signaling pathways.
- To determine if chemopreventive agents can target DCIS stem cells via miRNA activation.
Main Methods:
- Analysis of miRNA dysregulation in early breast cancer.
- Investigating the epigenetic activation of miRNA pathways by chemopreventive agents.
- Assessing the effect of chemopreventive agents on DCIS stem cells and tumor formation in vivo.
Main Results:
- miRNAs are dysregulated at the earliest stages of breast cancer (DCIS).
- Chemopreventive agents can epigenetically activate miRNA signaling pathways.
- Activated miRNAs target cancer stem cell signaling, inhibiting DCIS stem cells and blocking tumor formation.
- miRNAs play a role in regulating DCIS stem cells, influencing progression to invasive disease.
Conclusions:
- MicroRNAs are critical early targets for breast cancer chemoprevention.
- Dietary agents can activate tumor suppressor miRNAs, offering a novel strategy against DCIS.
- Targeting DCIS stem cells through miRNA activation presents a promising approach to prevent invasive breast cancer progression.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

